These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31780733)

  • 21. Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease.
    Mara AB; Gavitt TD; Tulman ER; Miller JM; He W; Reinhardt EM; Ozyck RG; Goodridge ML; Silbart LK; Szczepanek SM; Geary SJ
    NPJ Vaccines; 2022 Jul; 7(1):86. PubMed ID: 35906257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between α-SMA and ß-catenin levels in bronchoalveolar lavage fluid and severity of pneumonia.
    Li X; Jiang Z
    Pak J Med Sci; 2022; 38(3Part-I):600-604. PubMed ID: 35480522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.
    Asai N; Kato H; Mikamo H
    Respir Investig; 2022 Jul; 60(4):496-502. PubMed ID: 35422403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Clinical Related Factors of Severe Mycoplasma pneumoniae Pneumonia in Children Based on Imaging Diagnosis.
    Wang X; Lin X
    Comput Math Methods Med; 2022; 2022():4852131. PubMed ID: 35265171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irisin Activates M1 Macrophage and Suppresses Th2-Type Immune Response in Rats with Pelvic Inflammatory Disease.
    Zhang Z; Zhang C; Zhang S
    Evid Based Complement Alternat Med; 2022; 2022():5215915. PubMed ID: 35186099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the Nursing Effect of Respiratory Critical Illness Based on Refined Nursing Management.
    Shi W; Shen Y; Zhang B; Jin M; Qian J; Jin X
    Comput Math Methods Med; 2022; 2022():6458705. PubMed ID: 35178117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhausted and Apoptotic BALF T Cells in Proinflammatory Airway Milieu at Acute Phase of Severe Mycoplasma Pneumoniae Pneumonia in Children.
    Chen X; Liu F; Zheng B; Kang X; Wang X; Mou W; Zhang H; Jiao A; Zhao S; Gui J
    Front Immunol; 2021; 12():760488. PubMed ID: 35111152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Study Based on Metabolomics, Network Pharmacology, and Experimental Verification to Explore the Mechanism of Qinbaiqingfei Concentrated Pills in the treatment of Mycoplasma Pneumonia.
    Liu Z; Huo JH; Dong WT; Sun GD; Li FJ; Zhang YN; Qin ZW; Pengna J; Wang WM
    Front Pharmacol; 2021; 12():761883. PubMed ID: 34803705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With
    Wu TH; Wang NM; Liu FC; Pan HH; Huang FL; Fang YP; Chiang TW; Yang YY; Song CS; Wu HC; Lee CY
    Open Forum Infect Dis; 2021 Sep; 8(9):ofab416. PubMed ID: 34557557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children.
    Li M; Chen Y; Li H; Yang D; Zhou Y; Chen Z; Zhang Y
    BMC Infect Dis; 2021 Sep; 21(1):909. PubMed ID: 34481469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility Analysis in Several Mouse Strains Reveals Robust T-Cell Responses After
    Tamiya S; Yoshikawa E; Suzuki K; Yoshioka Y
    Front Cell Infect Microbiol; 2020; 10():602453. PubMed ID: 33520736
    [No Abstract]   [Full Text] [Related]  

  • 32.
    Pánisová E; Unger WWJ; Berger C; Meyer Sauteur PM
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):143-146. PubMed ID: 33385212
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children: A protocol for systematic review and meta-analysis.
    He H; Wang X; Xiao Y; Zheng J; Wang J; Zhang B
    Medicine (Baltimore); 2020 Dec; 99(51):e23747. PubMed ID: 33371133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children.
    Yang M; Meng F; Wang K; Gao M; Lu R; Li M; Zhao F; Huang L; Zhang Y; Cheng G; Wang X
    Sci Rep; 2017 Oct; 7(1):12934. PubMed ID: 29021577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and Expression of IL-17 and Related Cytokines in Children with Mycoplasma pneumoniae Pneumonia.
    Fan H; Lu B; Yang D; Zhang D; Shi T; Lu G
    Jpn J Infect Dis; 2019 Nov; 72(6):387-393. PubMed ID: 31257245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome analysis of bronchoalveolar lavage fluid from children with severe Mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency.
    Wang K; Gao M; Yang M; Meng F; Li D; Lu R; Wang Y; Zhuang H; Li M; Cheng G; Wang X
    Hum Genomics; 2017 Mar; 11(1):4. PubMed ID: 28302172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia.
    Deng F; Cao H; Liang X; Li Q; Yang Y; Zhao Z; Tan J; Fu G; Shu C
    Immun Inflamm Dis; 2023 May; 11(5):e849. PubMed ID: 37249293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia.
    Guo L; Liu F; Lu MP; Zheng Q; Chen ZM
    Pediatr Pulmonol; 2015 Aug; 50(8):814-9. PubMed ID: 25157471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia.
    Yang M; Meng F; Gao M; Cheng G; Wang X
    Sci Rep; 2019 Nov; 9(1):17853. PubMed ID: 31780733
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.